References Choquet-Kastylevsky G, Vial T, Descotes J
Uses The Food and Drug Administration (FDA) has approved both Januvia and Tradjenta to treat high blood sugar caused by type 2 diabetes in adults, along with diet and exercise
Nasal sprays also offer a rapid systemic absorption through the nasal mucosa
Available as an add-on to any IV therapy, typically in 200 mg increments and administered as a push at the end of your drip
Moreover, E-cadherin-mediated intercellular interactions downregulate TFRC and ACSL4, reducing ferroptosis sensitivity via the cadherin-Merlin-Hippo-YAP signaling pathway
[DOI] [PMC free article] [PubMed] [Google Scholar] 79.Hargreaves S.M., Rosenfeld D.L., Moreira A.V.B., Zandonadi R.P